Latest news by search query "compassionate use of remdesivir for patients with severe covid 19"

COVID-19’s effects on gene activity are caused indirectly, by inflammation, rather than by viral infiltration of the brain Three years have passed since we first came to know about COVID-19 and even now, much is unknown about this deadly virus. A new study has revealed that in case, you suffered from severe COVID infection, there is a high chance that your brain is aging faster than usual. The study, which has been published in Nature Aging, points out that gene activity inside the brain is more extensive in people who had severe COVID infections than in uninfected people who had been in an intensive care unit or had been put on ventilators to assist their breathing.

Beth Israel India Israel state Massachusets city Boston, state Massachusets covid-19 Ventilators infection

Black cancer patients more likely than Whites to have severe COVID

A US study of 3,506 cancer patients infected with SARS-CoV-2 in 2020 shows that Black patients were significantly more likely than their White peers to have severe illness, regardless of demographic and clinical risk factors and cancer type, status, and therapy at COVID-19 diagnosis.

Usa covid-19 patient Health

WHO clears arthritis drug for severe Covid-19 patients

Covid-19 treatments have been prequalified by WHO, including the three presentations. A prequalification provides assurances to countries that they are purchasing quality health products.

India covid-19 patient Health

Severe COVID-19: Could the nose be key to prevention?

Cell, suggests that the first response to SARS-CoV-2 infection in the nose and throat may determine the severity of the illness.A team from Boston Children’s Hospital, the Massachusetts Institute of Technology, and the University of Mississippi Medical Center looked at cells from the nose and throat of people with SARS-CoV-2 infections and compared these with the samples from healthy individuals who formed the control group.The researchers took nasal swabs from 35 adults with COVID-19 between April and September 2020.They then sequenced the RNA in each cell to see which cells contained RNA from the virus — showing they were infected — and which of the cell’s genes were turned on or off in response.The researchers found that more of the

state Massachusets city Boston state Mississippi covid-19 symptoms infection

U.S. events led to massive COVID-19 outbreak – mostly among fully vaccinated

COVID-19 at public events in a Massachusetts county had been fully vaccinated.The study, published on Friday, showed that three-quarters of those infected were fully vaccinated, suggesting the Delta variant of the virus is highly contagious.A separate CDC internal document, first reported by the Washington Post on Friday, described the Delta variant as being as transmissible as chickenpox and cautioned it could cause severe disease.

Delta Covid Washington state Massachusets virus covid-19 vaccine

Govt issues guidelines on Covid treatment for children, discourages use of Remdesivir. Details here

USE of STEROIDS and ANTI-COAGULANTS guideSteroids• Steroids are not indicated and are harmful in asymptomatic and mild cases of COVID-19• Indicated only in hospitalized moderately severe and critically ill COVID-19 cases under strict supervision• Steroids should be used at the right time, in right dose and for the right duration• Self-medication of steroids must be avoided• Indications and recommended dose: Corticosteroids may be used in rapidly progressive moderate and severe cases.

India covid-19 guidelines infection

Centre issues fresh advisory for use of Remdesivir in COVID-19 treatment. Details here

Never miss a story! Stay connected and informed with Mint. Download our App Now!!

India covid-19 information

‘He didn’t get to say goodbye to his mom’: COVID-19 leaves Peel Region teen orphaned

COVID-19 pandemic has claimed many lives and has had a devastating ripple effect on loved ones left behind.One young teen in Peel Region is experiencing it first hand after losing his mother to the virus on April 17, leaving him an orphan.“Losing your parent at any age is difficult. Losing both by the age of 13 is just unfathomable,” said Mariam Nouser, the cousin-in-law of Mazen Kamel.The Grade 7 student was the only child of 46-year-old Dalia Aly, who family say contracted COVID-19 from a friend back in March.

region Covid region Coronavirus covid-19

Statin users 50% less likely to die in hospital from severe COVID-19

40 million people living in the United States take statins to help reduce their cholesterol levels and risk of heart disease.But statins can also have a strong anti-inflammatory, anti-blood clotting, and antiviral effect, all of which may help limit complications associated with severe COVID-19. That is why researchers are trying to figure out if statin use impacts COVID-19 outcomes.In a new study, a group of researchers, including cardiologists caring for hospitalized COVID-19 patients in New York, set out to compare patient outcomes between people who had used statins before hospitalization and those who had not.

New York Usa hospital covid-19 patient Coronavirus

Facebook to use AI in predicting if Covid-19 patients need better healthcare

Click here to read the Mint ePaperMint is now on Telegram. Join Mint channel in your Telegram and stay updated with the latest business news.

covid-19 patient

Remdesivir combo reduces COVID-19 recovery time

A combination of the antiviral drug remdesivir and the anti-inflammatory drug baricitinib reduced recovery time and accelerated improvement, especially among patients receiving supplemental oxygen without invasive ventilation, according to a large, international study of hospitalized COVID-19 patients published in the New England Journal of Medicine today.

Usa hospital covid-19 patient

Covid cases rise in DC, WHO advised against the use of Remdesivir

World Health Organization advised against treating hospitalized coronavirus patients with Gilead Sciences Inc.’s Remdesivir, weeks after U.S. regulators granted the drug a speedy approval.The recommendation is a blow to the drug, one of the first thought to offer a meaningful benefit in treatment of coronavirus patients after a study showed it reduced their recovery time.

hospital covid-19 Coronavirus

NIH researchers find genetic link in patients with severe COVID-19

LOS ANGELES - Scientists at the National Institutes of Health (NIH) say they have found how genetics play a critical role in who develops severe cases of COVID-19 and why more men than women die from the illness. Much is still being learned about the novel coronavirus that has claimed the lives of more than 200,000 people in the U.S. Nearly 1 million deaths have been recorded worldwide to date, according to data tracked by Johns Hopkins University. Researchers have rushed to study the unpredictable and wide variations in illness severity that the virus causes in different people.

Los Angeles virus covid-19 symptoms patient

Race/Ethnicity, Underlying Medical Conditions, Homelessness, and Hospitalization Status of Adult Patients with COVID-19 at an Urban Safety-Net Medical Center — Boston, Massachusetts, 2020

1,2*; Erin M. Ashe, MPH1*; Michael Silverstein, MD1,2; Melissa Hofman, MSIS1; Samantha J. Lange, MPH3; Hilda Razzaghi, PhD3; Rebecca G.

state Massachusets state Maryland city Boston, state Massachusets county Clarke hospital covid-19 patient

pharmaceutical-technology.com

31.08.2020 / 12:57

79%

882

FDA grants EUA for Gilead’s remdesivir to treat Covid-19

Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.The US Food and Drug Administration (FDA) has granted emergency use authorisation (EUA) for Gilead Sciences’ Veklury (remdesivir) to treat all hospitalised patients with Covid-19. Previously, the drug received emergency authorisation for treating patients hospitalised with severe form of the disease.

Usa covid-19 information patient

Blood cancer patients face high risk of severe covid-19 symptoms

Covid-19, and those with blood diseases are in the most danger, researchers said.People with leukemia and other blood cancers who contract the coronavirus face as much as 57% higher odds of severe disease compared to those with breast cancer, according to a study published Monday in The Lancet Oncology journal.The pandemic has flooded hospitals with patients around the world, interrupting time-sensitive care for cancer and other conditions. The researchers studied data from from 60 centers in the U.K.

covid-19 symptoms patient Coronavirus

5 blood molecules linked to severe Covid-19 outcome in patients identified

novel coronavirus.The study, published in the journal Future Medicine, evaluated 299 patients diagnosed with COVID-19 admitted to the George Washington University (GW) Hospital between March 12 and May 9, 2020.It revealed that 200 of the patients had all five biomarker molecules being evaluated -- IL-6, D-dimer, CRP, LDH and ferritin.According to the researchers, including those from GW, elevated levels of these biomarkers were associated with inflammation and bleeding disorder, showing an independent increased risk for admission in the Intensive Care Unit (ICU), invasive ventilatory support, and death.They said the highest odds of death occurred when levels of the molecule LDH was greater than 1200 units per litre, and the D-dimer level

Washington, county George county George covid-19 death medicines patient

Tocilizumab trial did not benefit patients with severe covid-19: Roche

New Delhi: The Roche Group on Wednesday said that a clinical trial of its patented drug tocilizumab did not meet its primary and secondary endpoints, respectively, of improving clinical status of patients with covid-19 associated pneumonia and reducing patient mortality.The study, called COVACTA, is the first global, randomised, double-blind, placebo-controlled phase III trial of the drug.

city New Delhi Usa covid-19 pneumonia patient

pharmaceutical-technology.com

29.07.2020 / 14:19

51%

114

Health Canada authorises remdesivir as first Covid-19 treatment

Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.Health Canada has granted conditional approval to Gilead Sciences’ remdesivir (Veklury) to treat patients with severe Covid-19 who have pneumonia and need oxygen support. Remdesivir is the first drug authorised in the country for Covid-19 treatment.

Health Canada Canada covid-19 patient

Health Canada authorizes remdesivir to treat severe COVID-19

COVID-19 symptoms.The agency announced the decision in a press release Tuesday morning, saying this is the first drug Health Canada has authorized for the treatment of COVID-19. U.S.

Japan Singapore Canada covid-19 coronavirus news coronavirus update Coronavirus

Nonwhite patients more likely to have severe COVID-19, study finds

Radiology, provides further evidence of the disproportionate effects of issues concerning race and ethnicity on the severity of COVID-19.The sudden emergence and rapid spread of SARS-CoV-2 could arguably have been a leveler of social difference: In theory, anyone could catch the virus and risk a severe case of COVID-19, which can lead to death.However, as António Guterres, the secretary-general of the United Nations has noted, “The virus does not discriminate, but its impacts do, exposing deep weaknesses in the delivery of public services and structural inequalities that impede access to them.”One way that these structural inequalities have become apparent is the disproportionate effect of COVID-19 on people who are not white.The reasons

Antonio Guterres virus covid-19 patient

Distinct immune system pattern in severe Covid-19 patients identified: Study

COVID-19 pandemic continues, scientists worldwide continue to investigate the characteristics of the human immune response in fighting it.Seeking to expand on findings reported so far, and also to better connect immune features in COVID-19 patients with clinical features of disease, Mathew and his colleagues assessed the cells of the immune system in 125 COVID-19 patients at two points during their first week of hospitalisation.The researchers said they used a method called flow cytometry, which is a technique used to detect and measure physical and chemical characteristics of a population of cells, to assess the patient immune cells.They said the study also collected clinical data on the patient cohort.Combining the flow cytometric and

India covid-19 pandemic patient

pharmaceutical-technology.com

13.07.2020 / 14:31

72%

397

Australia’s TGA approves remdesivir as first Covid-19 treatment

Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.The Therapeutic Goods Administration (TGA) of Australia has awarded provisional approval for the use of Gilead Sciences’ remdesivir (Veklury) to treat Covid-19 patients, marking the first authorisation of treatment for this disease in the country. The approval enables the use of the drug in adults and adolescents hospitalised with severe Covid-19 symptoms.

Australia covid-19 infection patient

Baylor Scott & White releases results of study on the use of Remdesivir to treat COVID-19 patients

DALLAS - Baylor Scott & White is reporting some good news about treatment for COVID-19 patients.The hospital released some results of a study on the use of Remdesivir.Baylor Scott & White Health is one of 180 hospitals participating in a worldwide Gilead Sciences study of its antiviral drug Remdesivir to treat people who are severely hospitalized with COVID-19.MORE: Coronavirus coverage“What’s a patient come to a hospital for? They want to live longer, they want to live better, and they want to get better,” said Dr.

hospital covid-19 patient Coronavirus

pharmaceutical-technology.com

07.07.2020 / 14:01

48%

649

Mylan gets approval for emergency use of remdesivir for Covid-19

Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.Mylan has secured regulatory approval from the Drug Controller General of India (DCGI) for restricted emergency use of 100mg/vial remdesivir lyophilized powder to treat Covid-19. The approval is for suspected or laboratory-confirmed cases of Covid-19 in adults and children hospitalised with the severe form of the disease.

India covid-19 information patient

pharmaceutical-technology.com

06.07.2020 / 10:35

80%

150

Gilead gets EC conditional approval for remdesivir to treat Covid-19

Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.The European Commission (EC) has provided conditional marketing authorisation for Gilead Sciences to use Veklury (remdesivir) for the treatment of Covid-19. Gilead noted that the approval comes after a rolling review of supporting data that started in April.

covid-19 medicines patient

Coronavirus treatment: Health ministry revises remdesivir dosage for Covid-19 patients

COVID-19 patients from the earlier six-days to five-day treatment course.According to the Health Ministry, remdesivir drug is only for restricted emergency use on patients with moderate disease (those on oxygen support). The drug can not be administered to a pregnant or lactating mother and children below the age of 12 years.

covid-19 patient Coronavirus

‘She is going to make it, damn it’: One doctor’s quest to save her patient from Covid-19

BOSTON : The patient in Room 5 had one big thing going for her. She was young.Adriana Rice-Leiva, 31 years old and 7½ months pregnant, also had been in good health.

state Massachusets city Boston hospital doctor Ventilators patient

pharmaceutical-technology.com

22.06.2020 / 16:19

78%

806

Cipla and Hetero launch remdesivir to treat Covid-19 in India

Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.India-based companies Cipla and Hetero have separately launched remdesivir, which has been licensed from Gilead Sciences, for the treatment of Covid-19 in the country. Cipla introduced the drug in India under the brand name CIPREMI.

Gilead Sciences India covid-19 Government patient

Cipla surges 9% on launch of remdesivir generic for covid-19 treatment

₹663.80, up 4.2% from previous close, while the benchmark Sensex was up 1.1% at 35,104.71.In a notification to the exchanges, Cipla on Sunday announced the launch of its generic version of remdesivir.

Usa India covid-19 information Government patient

Important to use dexamethasone only for severe coronavirus cases: WHO

dexamethasone helpful in treating the critical patients dependent on ventilators or oxygen. Trial results announced on Tuesday by researchers in Britain showed dexamethasone, used since the 1960s to reduce inflammation in diseases such as arthritis, cut death rates by around a third among the most severely ill Covid-19 patients admitted to hospital."Dexamethasone, a common steroid, has been shown to have beneficial effect on patients severely ill with Covid-19.

Britain covid-19 Ventilators patient Coronavirus

Cancer patients at risk of severe covid-19

The Lancet.It compared test results and disease progression of 232 covid-19 patients who also had cancer with those of 519 covid-19 patients who did not suffer from cancer.These patients were admitted in hospitals between 13 January and 18 March.The group of patients who also had cancer was more vulnerable to covid-19 and was more likely than those without cancer to develop severe infection, the researchers found.Of those enrolled in the study, 64% of the cancer patients had severe covid-19, compared to only 32% of the non-cancer patients.

hospital covid-19 infection patient

Remdesivir, convalescent plasma Covid-19 use based on limited evidence: Govt

Click here to read the Mint ePaperLivemint.com is now on Telegram. Join Livemint channel in your Telegram and stay updated

India covid-19

pharmaceutical-technology.com

11.06.2020 / 13:23

53%

779

Singapore approves Gilead’s remdesivir to treat Covid-19

Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.Singapore’s Health Sciences Authority (HSA) has awarded conditional approval for Gilead Sciences Singapore’s experimental antiviral drug remdesivir, under the brand name Veklury, to treat adults with Covid-19. The drug is indicated for patients with oxygen saturation less than or equal to 94%, as well as those who need supplemental oxygen or intensive breathing support, including invasive mechanical ventilation.

Singapore city Singapore covid-19 patient

Study: Risk of severe COVID-19 imperils millions of uninsured

Even before the pandemic, more than 18 million Americans at high risk for COVID-19 complications lacked adequate health insurance, according to a study published today in the Journal of General Internal Medicine.

New York Usa state Massachusets city Cambridge, state Massachusets covid-19 pandemic prevention Coronavirus

Gilead says remdesivir helped moderate COVID-19 patients improve

Gilead said antiviral drug remdesivir reduced hospitalization stays by 31%, or about four days, compared to a placebo

Usa India hospital covid-19 patient

Taiwan approves Gilead's remdesivir to treat Covid-19

Governments are racing to bolster supplies of remdesivir, which US regulators this month approved for emergency use

Taiwan Usa state California covid-19 Government patient Coronavirus

Biocon Biologics allowed emergency use of CytoSorb in critical covid-19 patients

NEW DELHI: Biocon Biologics India Ltd on Wednesday said it has received approval from the Drug Controller General of India for emergency use of its device CytoSorb to reduce pro-inflammatory cytokines levels in critical covid-19 patients admitted in the intensive care unit (ICU).

city New Delhi India covid-19 pandemic doctor patient Coronavirus

Study: Remdesivir benefits some COVID-19 patients

A study published late last week in the New England Journal of Medicine found that hospitalized COVID-19 patients who received Gilead Sciences' antiviral drug remdesivir recovered a median of 4 days earlier than those who received a placebo.

Usa hospital covid-19 death patient

Amy Winehouse’s stilettos and Bono’s lyrics in new Island Records auction

The One Love Covid-19 Relief Auction takes place next week...

Bob Marley Annie Lennox Amy Winehouse Usa Britain state Indiana county Hill Jamaica covid-19 Pop NHS

pharmaceutical-technology.com

08.05.2020 / 10:33

66%

147

Japanese regulator approves Gilead’s remdesivir to treat Covid-19

Gilead Sciences has received approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) for its antiviral drug remdesivir, under the brand name Veklury, to treat Covid-19 infection.

Japan Usa covid-19 patient Coronavirus

pharmaceutical-technology.com

04.05.2020 / 09:21

53%

342

Gilead secures FDA’s EUA for remdesivir to treat Covid-19

Gilead Sciences has secured emergency use authorisation (EUA) from the US Food and Drug Administration (FDA) for remdesivir to treat Covid-19 infection.

Daniel Oday Usa covid-19 symptoms infection patient

FDA allows emergency use of remdesivir drug for coronavirus

The president received heavy criticism after claiming that injecting disinfectants could help treat COVID-19.

Washington covid-19 president patient Coronavirus

Gilead, Fauci say NIAID data show remdesivir can aid COVID-19 recovery

Gilead Sciences and National Institute of Allergy and Infectious Diseases (NIAID) Director Anthony Fauci, MD, said today that a NIAID study of the antiviral remdesivir has produced positive data on use of the drug for treating COVID-19.

Anthony Fauci state California hospital covid-19 patient

Severe COVID-19 patients have ‘unprecedented’ blood clots. Here’s what doctors know

Coronavirus patients may be at risk of potentially life-threatening blood clots, according to medical experts and emerging research.

city New York covid-19 coronavirus news coronavirus update Coronavirus

CSIR to test its new sepsis drug for severe patients of Covid-19

NEW DELHI : Raising hopes for a potential treatment of Covid-19, India’s premier research organization Council of Scientific and Industrial Research (CSIR) has decided to test its new drug against Sepsis to treat critical patients of Covid-19.

city New Delhi India city Ahmedabad covid-19 testing infection patient

Plasma from recovered coronavirus patients used to help current severe cases of COVID-19

ORLANDO, Fla. – People who have recovered after having coronavirus can help others who are still suffering from the illness by donating their blood plasma to be used in a new treatment.

state Florida city Orlando covid-19 donates patient Coronavirus

pharmaceutical-technology.com

06.04.2020 / 14:53

65%

287

Izana starts compassionate use study of potential Covid-19 drug

UK-based Izana Bioscience has launched a compassionate use study of namilumab (IZN-101) in patients with rapidly worsening Covid-19 in Bergamo and Milan, Italy.

China Italy Britain city Milan, Italy hospital virus covid-19 patient

United States	Cases: 46 252 513 Deaths: 750 423 Recovered: 0
India	Cases: 34 321 025 Deaths: 459 652 Recovered: 0
Brazil	Cases: 21 835 785 Deaths: 608 235 Recovered: 0
United Kingdom	Cases: 9 215 683 Deaths: 141 607 Recovered: 0
Russia	Cases: 8 494 589 Deaths: 237 619 Recovered: 0

Latest news by search query "compassionate use of remdesivir for patients with severe covid 19"

Related News